Literature DB >> 17277242

Combined endovenous ablation and transilluminated powered phlebectomy: is less invasive better?

Marc A Passman1, Jeffery B Dattilo, Raul J Guzman, Thomas C Naslund.   

Abstract

This study was undertaken to evaluate the evolution of operative vein approaches from combined "open" saphenous stripping-stab avulsion phlebectomy to combined "minimally invasive" endovenous ablation-transilluminated powered phlebectomy with a focus on comparing clinical outcomes. All patients undergoing a combined operative approach for concomitant saphenous vein insufficiency and associated varicose tributary veins between January 1, 1998 and December 31, 2005 were identified. Patients were stratified by operative approach into 3 groups: combined saphenous vein stripping-stab avulsion phlebectomy (STRIP-PHLEB); combined saphenous vein stripping-transilluminated phlebectomy (STRIP-TPP); and combined endovenous ablation-transilluminated phlebectomy (EVAB-TPP). Clinical volume, indications, technical details, and complications were retrospectively reviewed. Over the 8-year period, there were 72 limbs in 59 patients treated with STRIP-PHLEB, 92 limbs in 81 patients with STRIP-TPP, and 99 limbs in 76 patients with EVAB-TPP, with a time-dependent transition in operative techniques noted. There was no difference in distribution of CEAP clinical classification between groups, overall with most limbs in the C2-C4 categories (93.1%) and fewer in the C5-C6 categories (6.9%). There was no difference in overall complication rates between STRIP-PHLEB and EVAB-TPP, although the distribution of complications did shift with a trend toward more wound problems noted in procedures involving saphenous stripping (STRIP-PHLEB 5.6%, STRIP-TPP 6.5%, EVAB-TPP 2.0%; P = NS), and more hematomas in procedures involving transilluminated powered phlebectomy (STRIP-PHLEB 5.6%, STRIP-TPP 16.3%, EVAB-TPP 6.9%; P < .05; see Table 2). Complications associated with the endovenous ablation portion were low including technical inability to cannulate 1.6%, saphenous re-cannulation 2.4%, hematoma 2.4%, severe phlebitis 3.1%, venous thromboembolism 0.8%, and no wound or thermal injury problems. With the shift of combined operative vein approaches for concomitant saphenous vein insufficiency and varicose tributary veins towards "minimally invasive" techniques the overall complication rate has remained unchanged. While combined endovenous ablation-transilluminated phlebectomy offers some advantage of "less" invasiveness, this perceived benefit should be balanced against unchanged overall risk over traditional operative approaches.

Entities:  

Mesh:

Year:  2007        PMID: 17277242     DOI: 10.1177/1538574406296207

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  5 in total

1.  Outcome of transilluminated powered phlebectomy for varicose vein: review of 299 patients (447 limbs).

Authors:  Ji Won Kim; Jae Woong Han; So Young Jung; Man Sup Lim; Jae Pil Jung; Ji Woong Cho
Journal:  Surg Today       Date:  2012-03-06       Impact factor: 2.549

Review 2.  Strategies and challenges in treatment of varicose veins and venous insufficiency.

Authors:  Rong-Ding Gao; Song-Yi Qian; Hai-Hong Wang; Yong-Sheng Liu; Shi-Yan Ren
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

Review 3.  A review of the current management and treatment options for superficial venous insufficiency.

Authors:  Henry T Zhan; Ruth L Bush
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

4.  Treatment of varicose veins by transilluminated powered phlebectomy surgery: a 9-year experience.

Authors:  Randall W Franz; Jodi F Hartman; Michelle L Wright
Journal:  Int J Angiol       Date:  2012-12

5.  Pain is a Limiting Factor in Patients Suitable for Transilluminated Powered Phlebectomy.

Authors:  Alexander Kantarovsky; Dmitri Vinogradski; Evgenia Mankowitsch; Itamar Ashkenazi
Journal:  Rambam Maimonides Med J       Date:  2019-10-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.